Search

everythinglearnresearchcommunity

for

Search:↓

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Early diagnosis and treatment can reduce cicatricial alopecia in middle-aged individuals, especially females.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Baricitinib was effective in treating both early and late onset alopecia areata.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Medroxyprogesterone acetate is as effective as oral contraceptives for resuming ovulation in women with PCOS.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Combining lifestyle changes with personalized medication is crucial for better managing obesity in PCOS.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.